OpenAI acquires Orchestra Bio to accelerate drug development and advance new treatments in life sciences R&D.
Read the original at openai.com→OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Original headline: "OpenAI acquires Orchestra Bio"
Coverage timeline
- Oct 20, 00:00 UTC OpenAI lead source OpenAI acquires Orchestra Bio